Index by author

01 August 2001; volume 18, issue 2

A

  1. Aalbers, R.

    1. van der Woude, H.J., and R. Aalbers. "Unaltered perception of dyspnoea during treatment with long-acting β2-agonists." European Respiratory Journal 18.2 (2001): 269-271. Web. 18 April. 2019.

  2. Abisheganaden, J.

    1. Lee, P. et al "A new asthma severity index: a predictor of near-fatal asthma?." European Respiratory Journal 18.2 (2001): 272-278. Web. 18 April. 2019.

  3. Angarano, G.

    1. Antonucci, G. et al "Guidelines of tuberculosis preventive therapy for HIV-infected persons: a prospective, multicentre study." European Respiratory Journal 18.2 (2001): 369-375. Web. 18 April. 2019.

  4. Antonucci, G.

    1. Antonucci, G. et al "Guidelines of tuberculosis preventive therapy for HIV-infected persons: a prospective, multicentre study." European Respiratory Journal 18.2 (2001): 369-375. Web. 18 April. 2019.

  5. Antony, V.B.

    1. Antony, V.B. et al "Management of malignant pleural effusions." European Respiratory Journal 18.2 (2001): 402-419. Web. 18 April. 2019.

  6. Astoul, P.

    1. Antony, V.B. et al "Management of malignant pleural effusions." European Respiratory Journal 18.2 (2001): 402-419. Web. 18 April. 2019.

  7. Atasever, M.

    1. Yurdakul, A.S. et al "Resistance to penicillin among the Streptococcus pneumoniae in Turkey." European Respiratory Journal 18.2 (2001): 436. Web. 18 April. 2019.

  8. Aurora, P.

    1. Aurora, P. et al "Exercise tolerance in children with cystic fibrosis undergoing lung transplantation assessment." European Respiratory Journal 18.2 (2001): 293-297. Web. 18 April. 2019.

B

  1. Bach, F.H.

    1. Horváth, I. et al "“Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases”, summary of the ERS Research Seminar in Budapest, Hungary, September, 1999." European Respiratory Journal 18.2 (2001): 420-430. Web. 18 April. 2019.

  2. Badia, J.R.

    1. Badia, J.R. et al "Forced oscillation measurements do not affect upper airway muscle tone or sleep in clinical studies." European Respiratory Journal 18.2 (2001): 335-339. Web. 18 April. 2019.

  3. Balfour-Lynn, I.M.

    1. Aurora, P. et al "Exercise tolerance in children with cystic fibrosis undergoing lung transplantation assessment." European Respiratory Journal 18.2 (2001): 293-297. Web. 18 April. 2019.

  4. Barnes, P.J.

    1. Horváth, I. et al "“Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases”, summary of the ERS Research Seminar in Budapest, Hungary, September, 1999." European Respiratory Journal 18.2 (2001): 420-430. Web. 18 April. 2019.

  5. Bastian-Lee, Y.

    1. Chavasse, R.J., Y. Bastian-Lee, and P. Seddon. "Comparison of resistance measured by the interrupter technique and by passive mechanics in sedated infants." European Respiratory Journal 18.2 (2001): 330-334. Web. 18 April. 2019.

  6. Bergeron, A.

    1. Bergeron, A. et al "Computed tomography of pulmonary sarcoid-like granulomas induced by complete Freund's adjuvant in rats." European Respiratory Journal 18.2 (2001): 357-361. Web. 18 April. 2019.

  7. Blazy, I.

    1. Schneider, J-C. et al "Response of nitric oxide pathway to l-arginine infusion at the altitude of 4,350 m." European Respiratory Journal 18.2 (2001): 286-292. Web. 18 April. 2019.

  8. Boissinot, E.

    1. Dequin, P-F. et al "Urinary excretion reflects lung deposition of aminoglycoside aerosols in cystic fibrosis." European Respiratory Journal 18.2 (2001): 316-322. Web. 18 April. 2019.

  9. Boutin, C.

    1. Antony, V.B. et al "Management of malignant pleural effusions." European Respiratory Journal 18.2 (2001): 402-419. Web. 18 April. 2019.

  10. Bradford, A.

    1. McGuire, M., and A. Bradford. "Chronic intermittent hypercapnic hypoxia increases pulmonary arterial pressure and haematocrit in rats." European Respiratory Journal 18.2 (2001): 279-285. Web. 18 April. 2019.

  11. Bricault, I.

    1. Ferretti, G.R., I. Bricault, and M. Coulomb. "Virtual tools for imaging of the thorax." European Respiratory Journal 18.2 (2001): 381-392. Web. 18 April. 2019.

  12. Bugge, M.

    1. Riise, G.C. et al "A 40-yr-old male with cough, haemoptysis and increasing dyspnoea." European Respiratory Journal 18.2 (2001): 432-435. Web. 18 April. 2019.

  13. Buhl, R.

    1. Solèr, M. et al "The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics." European Respiratory Journal 18.2 (2001): 254-261. Web. 18 April. 2019.
    2. Zetterström, O. et al "Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone." European Respiratory Journal 18.2 (2001): 262-268. Web. 18 April. 2019.

C

  1. Çalişir, H.C.

    1. Yurdakul, A.S. et al "Resistance to penicillin among the Streptococcus pneumoniae in Turkey." European Respiratory Journal 18.2 (2001): 436. Web. 18 April. 2019.

  2. Chanez, P.

    1. Chanez, P.. "Immunological intervention with anti-immunoglobulin-E antibody to prevent asthma exacerbations." European Respiratory Journal 18.2 (2001): 249-250. Web. 18 April. 2019.

  3. Chaouat, A.

    1. Weitzenblum, E., and A. Chaouat. "Hypoxic pulmonary hypertension in man: what minimum daily duration of hypoxaemia is required?." European Respiratory Journal 18.2 (2001): 251-253. Web. 18 April. 2019.

  4. Chavasse, R.J.

    1. Chavasse, R.J., Y. Bastian-Lee, and P. Seddon. "Comparison of resistance measured by the interrupter technique and by passive mechanics in sedated infants." European Respiratory Journal 18.2 (2001): 330-334. Web. 18 April. 2019.

  5. Chee, C.B.E.

    1. Lee, P. et al "A new asthma severity index: a predictor of near-fatal asthma?." European Respiratory Journal 18.2 (2001): 272-278. Web. 18 April. 2019.

  6. Chinn, S.

    1. Chinn, S.. "Statistics for the European Respiratory Journal." European Respiratory Journal 18.2 (2001): 393-401. Web. 18 April. 2019.

  7. Chirianni, A.

    1. Antonucci, G. et al "Guidelines of tuberculosis preventive therapy for HIV-infected persons: a prospective, multicentre study." European Respiratory Journal 18.2 (2001): 369-375. Web. 18 April. 2019.

  8. Choi, A.M.K.

    1. Horváth, I. et al "“Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases”, summary of the ERS Research Seminar in Budapest, Hungary, September, 1999." European Respiratory Journal 18.2 (2001): 420-430. Web. 18 April. 2019.

  9. Chung, K.F.

    1. Horváth, I. et al "“Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases”, summary of the ERS Research Seminar in Budapest, Hungary, September, 1999." European Respiratory Journal 18.2 (2001): 420-430. Web. 18 April. 2019.

  10. Coulomb, M.

    1. Ferretti, G.R., I. Bricault, and M. Coulomb. "Virtual tools for imaging of the thorax." European Respiratory Journal 18.2 (2001): 381-392. Web. 18 April. 2019.

D

  1. Dankert-Roelse, J.E.

    1. Mérelle, M.E. et al "Influence of neonatal screening and centralized treatment on long-term clinical outcome and survival of CF patients." European Respiratory Journal 18.2 (2001): 306-315. Web. 18 April. 2019.

  2. Déchaux, M.

    1. Schneider, J-C. et al "Response of nitric oxide pathway to l-arginine infusion at the altitude of 4,350 m." European Respiratory Journal 18.2 (2001): 286-292. Web. 18 April. 2019.

  3. de Gialluly, C.

    1. Dequin, P-F. et al "Urinary excretion reflects lung deposition of aminoglycoside aerosols in cystic fibrosis." European Respiratory Journal 18.2 (2001): 316-322. Web. 18 April. 2019.

  4. Dekhuijzen, P.N.R.

    1. Horváth, I. et al "“Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases”, summary of the ERS Research Seminar in Budapest, Hungary, September, 1999." European Respiratory Journal 18.2 (2001): 420-430. Web. 18 April. 2019.

  5. Delatour, F.

    1. Dequin, P-F. et al "Urinary excretion reflects lung deposition of aminoglycoside aerosols in cystic fibrosis." European Respiratory Journal 18.2 (2001): 316-322. Web. 18 April. 2019.

  6. Della Cioppa, G.

    1. Solèr, M. et al "The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics." European Respiratory Journal 18.2 (2001): 254-261. Web. 18 April. 2019.

  7. Dequin, P-F.

    1. Dequin, P-F. et al "Urinary excretion reflects lung deposition of aminoglycoside aerosols in cystic fibrosis." European Respiratory Journal 18.2 (2001): 316-322. Web. 18 April. 2019.

  8. Dinwiddie, R.

    1. Aurora, P. et al "Exercise tolerance in children with cystic fibrosis undergoing lung transplantation assessment." European Respiratory Journal 18.2 (2001): 293-297. Web. 18 April. 2019.

  9. Diot, P.

    1. Dequin, P-F. et al "Urinary excretion reflects lung deposition of aminoglycoside aerosols in cystic fibrosis." European Respiratory Journal 18.2 (2001): 316-322. Web. 18 April. 2019.

  10. Donnelly, L.E.

    1. Horváth, I. et al "“Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases”, summary of the ERS Research Seminar in Budapest, Hungary, September, 1999." European Respiratory Journal 18.2 (2001): 420-430. Web. 18 April. 2019.

  11. Döring, G.

    1. Horváth, I. et al "“Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases”, summary of the ERS Research Seminar in Budapest, Hungary, September, 1999." European Respiratory Journal 18.2 (2001): 420-430. Web. 18 April. 2019.

E

  1. Ekström, T.

    1. Zetterström, O. et al "Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone." European Respiratory Journal 18.2 (2001): 262-268. Web. 18 April. 2019.

F

  1. Farré, R.

    1. Badia, J.R. et al "Forced oscillation measurements do not affect upper airway muscle tone or sleep in clinical studies." European Respiratory Journal 18.2 (2001): 335-339. Web. 18 April. 2019.

  2. Faurisson, F.

    1. Dequin, P-F. et al "Urinary excretion reflects lung deposition of aminoglycoside aerosols in cystic fibrosis." European Respiratory Journal 18.2 (2001): 316-322. Web. 18 April. 2019.

  3. Fehrenbach, H.

    1. Koslowski, R. et al "Changes in xylosyltransferase activity and in proteoglycan deposition in bleomycin-induced lung injury in rat." European Respiratory Journal 18.2 (2001): 347-356. Web. 18 April. 2019.

  4. Ferretti, G.R.

    1. Ferretti, G.R., I. Bricault, and M. Coulomb. "Virtual tools for imaging of the thorax." European Respiratory Journal 18.2 (2001): 381-392. Web. 18 April. 2019.

  5. Fjällbrant, H.

    1. Fjällbrant, H., M. Ridell, and L.O. Larsson. "The tuberculin skin test in relation to immunological in vitro reactions in BCG-vaccinated healthcare workers." European Respiratory Journal 18.2 (2001): 376-380. Web. 18 April. 2019.

  6. Fox, H.

    1. Solèr, M. et al "The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics." European Respiratory Journal 18.2 (2001): 254-261. Web. 18 April. 2019.

G

  1. Gerritsen, J.

    1. Mérelle, M.E. et al "Influence of neonatal screening and centralized treatment on long-term clinical outcome and survival of CF patients." European Respiratory Journal 18.2 (2001): 306-315. Web. 18 April. 2019.

  2. Girardi, E.

    1. Antonucci, G. et al "Guidelines of tuberculosis preventive therapy for HIV-infected persons: a prospective, multicentre study." European Respiratory Journal 18.2 (2001): 369-375. Web. 18 April. 2019.

  3. Goldstraw, P.

    1. Antony, V.B. et al "Management of malignant pleural effusions." European Respiratory Journal 18.2 (2001): 402-419. Web. 18 April. 2019.

  4. Gupta, N.

    1. Solèr, M. et al "The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics." European Respiratory Journal 18.2 (2001): 254-261. Web. 18 April. 2019.

H

  1. Hance, A.J.

    1. Bergeron, A. et al "Computed tomography of pulmonary sarcoid-like granulomas induced by complete Freund's adjuvant in rats." European Respiratory Journal 18.2 (2001): 357-361. Web. 18 April. 2019.

  2. Harms, H.K.

    1. Navarro, J. et al "Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF." European Respiratory Journal 18.2 (2001): 298-305. Web. 18 April. 2019.

  3. Hedman, J.

    1. Zetterström, O. et al "Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone." European Respiratory Journal 18.2 (2001): 262-268. Web. 18 April. 2019.

  4. Henderson, A.J.

    1. Henderson, A.J. et al "Pre- and postnatal parental smoking and wheeze in infancy: cross cultural differences." European Respiratory Journal 18.2 (2001): 323-329. Web. 18 April. 2019.

  5. Hodson, M.E.

    1. Navarro, J. et al "Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF." European Respiratory Journal 18.2 (2001): 298-305. Web. 18 April. 2019.

  6. Horváth, I.

    1. Horváth, I. et al "“Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases”, summary of the ERS Research Seminar in Budapest, Hungary, September, 1999." European Respiratory Journal 18.2 (2001): 420-430. Web. 18 April. 2019.

  7. Hott, J.

    1. Antony, V.B. et al "Management of malignant pleural effusions." European Respiratory Journal 18.2 (2001): 402-419. Web. 18 April. 2019.

  8. Hruba, D.

    1. Henderson, A.J. et al "Pre- and postnatal parental smoking and wheeze in infancy: cross cultural differences." European Respiratory Journal 18.2 (2001): 323-329. Web. 18 April. 2019.

I

  1. Ippolito, G.

    1. Antonucci, G. et al "Guidelines of tuberculosis preventive therapy for HIV-infected persons: a prospective, multicentre study." European Respiratory Journal 18.2 (2001): 369-375. Web. 18 April. 2019.

J

  1. Johnsson, Å.A.

    1. Riise, G.C. et al "A 40-yr-old male with cough, haemoptysis and increasing dyspnoea." European Respiratory Journal 18.2 (2001): 432-435. Web. 18 April. 2019.

K

  1. Kasper, M.

    1. Koslowski, R. et al "Changes in xylosyltransferase activity and in proteoglycan deposition in bleomycin-induced lung injury in rat." European Respiratory Journal 18.2 (2001): 347-356. Web. 18 April. 2019.

  2. Kelly, F.J.

    1. Horváth, I. et al "“Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases”, summary of the ERS Research Seminar in Budapest, Hungary, September, 1999." European Respiratory Journal 18.2 (2001): 420-430. Web. 18 April. 2019.

  3. Khamaysi, I.

    1. Oksenberg, A., I. Khamaysi, and D.S. Silverberg. "Apnoea characteristics across the night in severe obstructive sleep apnoea: influence of body posture." European Respiratory Journal 18.2 (2001): 340-346. Web. 18 April. 2019.

  4. Koch, C.

    1. Navarro, J. et al "Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF." European Respiratory Journal 18.2 (2001): 298-305. Web. 18 April. 2019.

  5. Koslowski, R.

    1. Koslowski, R. et al "Changes in xylosyltransferase activity and in proteoglycan deposition in bleomycin-induced lung injury in rat." European Respiratory Journal 18.2 (2001): 347-356. Web. 18 April. 2019.

  6. Kukla, L.

    1. Henderson, A.J. et al "Pre- and postnatal parental smoking and wheeze in infancy: cross cultural differences." European Respiratory Journal 18.2 (2001): 323-329. Web. 18 April. 2019.

L

  1. Laissy, J-P.

    1. Bergeron, A. et al "Computed tomography of pulmonary sarcoid-like granulomas induced by complete Freund's adjuvant in rats." European Respiratory Journal 18.2 (2001): 357-361. Web. 18 April. 2019.

  2. Larsson, L.O.

    1. Fjällbrant, H., M. Ridell, and L.O. Larsson. "The tuberculin skin test in relation to immunological in vitro reactions in BCG-vaccinated healthcare workers." European Respiratory Journal 18.2 (2001): 376-380. Web. 18 April. 2019.

  3. Lauria, F.N.

    1. Antonucci, G. et al "Guidelines of tuberculosis preventive therapy for HIV-infected persons: a prospective, multicentre study." European Respiratory Journal 18.2 (2001): 369-375. Web. 18 April. 2019.

  4. Lee, P.

    1. Lee, P. et al "A new asthma severity index: a predictor of near-fatal asthma?." European Respiratory Journal 18.2 (2001): 272-278. Web. 18 April. 2019.

  5. Lemarié, E.

    1. Dequin, P-F. et al "Urinary excretion reflects lung deposition of aminoglycoside aerosols in cystic fibrosis." European Respiratory Journal 18.2 (2001): 316-322. Web. 18 April. 2019.

  6. Lim, W.S.

    1. Lim, W.S., and J.T. Macfarlane. "A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia." European Respiratory Journal 18.2 (2001): 362-368. Web. 18 April. 2019.

  7. Loddenkemper, R.

    1. Antony, V.B. et al "Management of malignant pleural effusions." European Respiratory Journal 18.2 (2001): 402-419. Web. 18 April. 2019.

  8. Loiseau, P.

    1. Bergeron, A. et al "Computed tomography of pulmonary sarcoid-like granulomas induced by complete Freund's adjuvant in rats." European Respiratory Journal 18.2 (2001): 357-361. Web. 18 April. 2019.

M

  1. Macfarlane, J.T.

    1. Lim, W.S., and J.T. Macfarlane. "A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia." European Respiratory Journal 18.2 (2001): 362-368. Web. 18 April. 2019.

  2. MacNee, W.

    1. Horváth, I. et al "“Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases”, summary of the ERS Research Seminar in Budapest, Hungary, September, 1999." European Respiratory Journal 18.2 (2001): 420-430. Web. 18 April. 2019.

  3. Marchand, S.

    1. Dequin, P-F. et al "Urinary excretion reflects lung deposition of aminoglycoside aerosols in cystic fibrosis." European Respiratory Journal 18.2 (2001): 316-322. Web. 18 April. 2019.

  4. Mason, N.P.

    1. Schneider, J-C. et al "Response of nitric oxide pathway to l-arginine infusion at the altitude of 4,350 m." European Respiratory Journal 18.2 (2001): 286-292. Web. 18 April. 2019.

  5. Mastella, G.

    1. Navarro, J. et al "Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF." European Respiratory Journal 18.2 (2001): 298-305. Web. 18 April. 2019.

  6. Matz, J.

    1. Solèr, M. et al "The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics." European Respiratory Journal 18.2 (2001): 254-261. Web. 18 April. 2019.

  7. McGuire, M.

    1. McGuire, M., and A. Bradford. "Chronic intermittent hypercapnic hypoxia increases pulmonary arterial pressure and haematocrit in rats." European Respiratory Journal 18.2 (2001): 279-285. Web. 18 April. 2019.

  8. McKenzie, S.G.

    1. Navarro, J. et al "Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF." European Respiratory Journal 18.2 (2001): 298-305. Web. 18 April. 2019.

  9. Mellem, H.

    1. Zetterström, O. et al "Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone." European Respiratory Journal 18.2 (2001): 262-268. Web. 18 April. 2019.

  10. Mérelle, M.E.

    1. Mérelle, M.E. et al "Influence of neonatal screening and centralized treatment on long-term clinical outcome and survival of CF patients." European Respiratory Journal 18.2 (2001): 306-315. Web. 18 April. 2019.

  11. Montserrat, J.M.

    1. Badia, J.R. et al "Forced oscillation measurements do not affect upper airway muscle tone or sleep in clinical studies." European Respiratory Journal 18.2 (2001): 335-339. Web. 18 April. 2019.

N

  1. Navajas, D.

    1. Badia, J.R. et al "Forced oscillation measurements do not affect upper airway muscle tone or sleep in clinical studies." European Respiratory Journal 18.2 (2001): 335-339. Web. 18 April. 2019.

  2. Navarro, J.

    1. Navarro, J. et al "Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF." European Respiratory Journal 18.2 (2001): 298-305. Web. 18 April. 2019.

  3. Northstone, K.

    1. Henderson, A.J. et al "Pre- and postnatal parental smoking and wheeze in infancy: cross cultural differences." European Respiratory Journal 18.2 (2001): 323-329. Web. 18 April. 2019.

O

  1. O'Brien, J.

    1. Solèr, M. et al "The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics." European Respiratory Journal 18.2 (2001): 254-261. Web. 18 April. 2019.

  2. O'Neill, S.

    1. Zetterström, O. et al "Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone." European Respiratory Journal 18.2 (2001): 262-268. Web. 18 April. 2019.

  3. Öğretensoy, M.

    1. Yurdakul, A.S. et al "Resistance to penicillin among the Streptococcus pneumoniae in Turkey." European Respiratory Journal 18.2 (2001): 436. Web. 18 April. 2019.

  4. Oksenberg, A.

    1. Oksenberg, A., I. Khamaysi, and D.S. Silverberg. "Apnoea characteristics across the night in severe obstructive sleep apnoea: influence of body posture." European Respiratory Journal 18.2 (2001): 340-346. Web. 18 April. 2019.

  5. Ordulu, L.

    1. Yurdakul, A.S. et al "Resistance to penicillin among the Streptococcus pneumoniae in Turkey." European Respiratory Journal 18.2 (2001): 436. Web. 18 April. 2019.

P

  1. Pagano, G.

    1. Antonucci, G. et al "Guidelines of tuberculosis preventive therapy for HIV-infected persons: a prospective, multicentre study." European Respiratory Journal 18.2 (2001): 369-375. Web. 18 April. 2019.

  2. Perpiñá, M.

    1. Zetterström, O. et al "Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone." European Respiratory Journal 18.2 (2001): 262-268. Web. 18 April. 2019.

  3. Pfeil, U.

    1. Koslowski, R. et al "Changes in xylosyltransferase activity and in proteoglycan deposition in bleomycin-induced lung injury in rat." European Respiratory Journal 18.2 (2001): 347-356. Web. 18 April. 2019.

  4. Phillips, M.

    1. Horváth, I. et al "“Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases”, summary of the ERS Research Seminar in Budapest, Hungary, September, 1999." European Respiratory Journal 18.2 (2001): 420-430. Web. 18 April. 2019.

  5. Prasad, S.A.

    1. Aurora, P. et al "Exercise tolerance in children with cystic fibrosis undergoing lung transplantation assessment." European Respiratory Journal 18.2 (2001): 293-297. Web. 18 April. 2019.

R

  1. Rabier, D.

    1. Schneider, J-C. et al "Response of nitric oxide pathway to l-arginine infusion at the altitude of 4,350 m." European Respiratory Journal 18.2 (2001): 286-292. Web. 18 April. 2019.

  2. Rainisio, M.

    1. Navarro, J. et al "Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF." European Respiratory Journal 18.2 (2001): 298-305. Web. 18 April. 2019.

  3. Raviglione, M.

    1. Antonucci, G. et al "Guidelines of tuberculosis preventive therapy for HIV-infected persons: a prospective, multicentre study." European Respiratory Journal 18.2 (2001): 369-375. Web. 18 April. 2019.

  4. Richalet, J-P.

    1. Schneider, J-C. et al "Response of nitric oxide pathway to l-arginine infusion at the altitude of 4,350 m." European Respiratory Journal 18.2 (2001): 286-292. Web. 18 April. 2019.

  5. Ridell, M.

    1. Fjällbrant, H., M. Ridell, and L.O. Larsson. "The tuberculin skin test in relation to immunological in vitro reactions in BCG-vaccinated healthcare workers." European Respiratory Journal 18.2 (2001): 376-380. Web. 18 April. 2019.

  6. Rigau, J.

    1. Badia, J.R. et al "Forced oscillation measurements do not affect upper airway muscle tone or sleep in clinical studies." European Respiratory Journal 18.2 (2001): 335-339. Web. 18 April. 2019.

  7. Riise, G.C.

    1. Riise, G.C. et al "A 40-yr-old male with cough, haemoptysis and increasing dyspnoea." European Respiratory Journal 18.2 (2001): 432-435. Web. 18 April. 2019.

  8. Rodriguez Panadero, F.

    1. Antony, V.B. et al "Management of malignant pleural effusions." European Respiratory Journal 18.2 (2001): 402-419. Web. 18 April. 2019.

S

  1. Sahn, S.A.

    1. Antony, V.B. et al "Management of malignant pleural effusions." European Respiratory Journal 18.2 (2001): 402-419. Web. 18 April. 2019.

  2. Schneider, J-C.

    1. Schneider, J-C. et al "Response of nitric oxide pathway to l-arginine infusion at the altitude of 4,350 m." European Respiratory Journal 18.2 (2001): 286-292. Web. 18 April. 2019.

  3. Schouman-Claeys, E.

    1. Bergeron, A. et al "Computed tomography of pulmonary sarcoid-like granulomas induced by complete Freund's adjuvant in rats." European Respiratory Journal 18.2 (2001): 357-361. Web. 18 April. 2019.

  4. Schouten, J.P.

    1. Mérelle, M.E. et al "Influence of neonatal screening and centralized treatment on long-term clinical outcome and survival of CF patients." European Respiratory Journal 18.2 (2001): 306-315. Web. 18 April. 2019.

  5. Seddon, P.

    1. Chavasse, R.J., Y. Bastian-Lee, and P. Seddon. "Comparison of resistance measured by the interrupter technique and by passive mechanics in sedated infants." European Respiratory Journal 18.2 (2001): 330-334. Web. 18 April. 2019.

  6. Sherriff, A.

    1. Henderson, A.J. et al "Pre- and postnatal parental smoking and wheeze in infancy: cross cultural differences." European Respiratory Journal 18.2 (2001): 323-329. Web. 18 April. 2019.

  7. Silverberg, D.S.

    1. Oksenberg, A., I. Khamaysi, and D.S. Silverberg. "Apnoea characteristics across the night in severe obstructive sleep apnoea: influence of body posture." European Respiratory Journal 18.2 (2001): 340-346. Web. 18 April. 2019.

  8. Skutelsky, E.

    1. Koslowski, R. et al "Changes in xylosyltransferase activity and in proteoglycan deposition in bleomycin-induced lung injury in rat." European Respiratory Journal 18.2 (2001): 347-356. Web. 18 April. 2019.

  9. Slade, G.

    1. Aurora, P. et al "Exercise tolerance in children with cystic fibrosis undergoing lung transplantation assessment." European Respiratory Journal 18.2 (2001): 293-297. Web. 18 April. 2019.

  10. Solèr, M.

    1. Solèr, M. et al "The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics." European Respiratory Journal 18.2 (2001): 254-261. Web. 18 April. 2019.

  11. Strandvik, B.

    1. Navarro, J. et al "Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF." European Respiratory Journal 18.2 (2001): 298-305. Web. 18 April. 2019.

  12. Suter, F.

    1. Antonucci, G. et al "Guidelines of tuberculosis preventive therapy for HIV-infected persons: a prospective, multicentre study." European Respiratory Journal 18.2 (2001): 369-375. Web. 18 April. 2019.

T

  1. Tazi, A.

    1. Bergeron, A. et al "Computed tomography of pulmonary sarcoid-like granulomas induced by complete Freund's adjuvant in rats." European Respiratory Journal 18.2 (2001): 357-361. Web. 18 April. 2019.

  2. Thirlwell, J.

    1. Solèr, M. et al "The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics." European Respiratory Journal 18.2 (2001): 254-261. Web. 18 April. 2019.

  3. Townley, R.

    1. Solèr, M. et al "The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics." European Respiratory Journal 18.2 (2001): 254-261. Web. 18 April. 2019.

U

  1. Uribe, M.E.

    1. Badia, J.R. et al "Forced oscillation measurements do not affect upper airway muscle tone or sleep in clinical studies." European Respiratory Journal 18.2 (2001): 335-339. Web. 18 April. 2019.

V

  1. Valat, C.

    1. Dequin, P-F. et al "Urinary excretion reflects lung deposition of aminoglycoside aerosols in cystic fibrosis." European Respiratory Journal 18.2 (2001): 316-322. Web. 18 April. 2019.

  2. Vanacore, P.

    1. Antonucci, G. et al "Guidelines of tuberculosis preventive therapy for HIV-infected persons: a prospective, multicentre study." European Respiratory Journal 18.2 (2001): 369-375. Web. 18 April. 2019.

  3. van der Woude, H.J.

    1. van der Woude, H.J., and R. Aalbers. "Unaltered perception of dyspnoea during treatment with long-acting β2-agonists." European Respiratory Journal 18.2 (2001): 269-271. Web. 18 April. 2019.

W

  1. Wang, Y.T.

    1. Lee, P. et al "A new asthma severity index: a predictor of near-fatal asthma?." European Respiratory Journal 18.2 (2001): 272-278. Web. 18 April. 2019.

  2. Weitzenblum, E.

    1. Weitzenblum, E., and A. Chaouat. "Hypoxic pulmonary hypertension in man: what minimum daily duration of hypoxaemia is required?." European Respiratory Journal 18.2 (2001): 251-253. Web. 18 April. 2019.

  3. Wenzel, K-W.

    1. Koslowski, R. et al "Changes in xylosyltransferase activity and in proteoglycan deposition in bleomycin-induced lung injury in rat." European Respiratory Journal 18.2 (2001): 347-356. Web. 18 April. 2019.

  4. Whitehead, B.

    1. Aurora, P. et al "Exercise tolerance in children with cystic fibrosis undergoing lung transplantation assessment." European Respiratory Journal 18.2 (2001): 293-297. Web. 18 April. 2019.

  5. Willén, H.

    1. Riise, G.C. et al "A 40-yr-old male with cough, haemoptysis and increasing dyspnoea." European Respiratory Journal 18.2 (2001): 432-435. Web. 18 April. 2019.

  6. Willis, D.

    1. Horváth, I. et al "“Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases”, summary of the ERS Research Seminar in Budapest, Hungary, September, 1999." European Respiratory Journal 18.2 (2001): 420-430. Web. 18 April. 2019.

Y

  1. Yamaya, M.

    1. Horváth, I. et al "“Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases”, summary of the ERS Research Seminar in Budapest, Hungary, September, 1999." European Respiratory Journal 18.2 (2001): 420-430. Web. 18 April. 2019.

  2. Yurdakul, A.S.

    1. Yurdakul, A.S. et al "Resistance to penicillin among the Streptococcus pneumoniae in Turkey." European Respiratory Journal 18.2 (2001): 436. Web. 18 April. 2019.

Z

  1. Zetterström, O.

    1. Zetterström, O. et al "Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone." European Respiratory Journal 18.2 (2001): 262-268. Web. 18 April. 2019.
Back to top

Search Within This Issue

Jump to

Manage Table of content Alerts